Haverford Trust Co purchased a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 6,955 shares of the financial services provider's stock, valued at approximately $1,159,000.
Several other hedge funds also recently made changes to their positions in the company. Solstein Capital LLC purchased a new stake in Marsh & McLennan Companies in the fourth quarter valued at approximately $25,000. Asset Dedication LLC purchased a new position in shares of Marsh & McLennan Companies during the first quarter worth approximately $25,000. SHP Wealth Management acquired a new position in shares of Marsh & McLennan Companies in the 4th quarter valued at $26,000. KERR FINANCIAL PLANNING Corp purchased a new stake in Marsh & McLennan Companies in the 4th quarter valued at $27,000. Finally, Golden State Wealth Management LLC acquired a new stake in Marsh & McLennan Companies during the 4th quarter worth $27,000. Hedge funds and other institutional investors own 87.99% of the company's stock.
Analyst Upgrades and Downgrades
Several analysts have commented on the company. Piper Sandler reduced their price objective on Marsh & McLennan Companies from $190.00 to $182.00 and set a "neutral" rating for the company in a research note on Tuesday, May 26th. Mizuho boosted their target price on Marsh & McLennan Companies from $197.00 to $201.00 and gave the company a "neutral" rating in a report on Wednesday, July 22nd. UBS Group upped their price target on Marsh & McLennan Companies from $212.00 to $216.00 and gave the stock a "buy" rating in a research note on Monday, July 27th. JPMorgan Chase & Co. lifted their price objective on shares of Marsh & McLennan Companies from $206.00 to $212.00 and gave the company an "overweight" rating in a research report on Monday, July 13th. Finally, Cantor Fitzgerald boosted their price objective on shares of Marsh & McLennan Companies from $210.00 to $218.00 and gave the company an "overweight" rating in a research note on Thursday, July 9th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Marsh & McLennan Companies presently has an average rating of "Hold" and a consensus target price of $203.50.
Read Our Latest Stock Report on Marsh & McLennan Companies
Insider Activity at Marsh & McLennan Companies
In related news, Director Lloyd M. Yates sold 12,000 shares of the stock in a transaction that occurred on Thursday, July 23rd. The shares were sold at an average price of $175.65, for a total transaction of $2,107,800.00. Following the completion of the sale, the director owned 12,001 shares of the company's stock, valued at approximately $2,107,975.65. This represents a 50.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO John Q. Doyle sold 16,656 shares of the stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the sale, the chief executive officer directly owned 116,811 shares of the company's stock, valued at $18,889,506.81. The trade was a 12.48% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 36,469 shares of company stock valued at $6,291,345 over the last three months. Insiders own 0.38% of the company's stock.
Marsh & McLennan Companies Stock Performance
MRSH opened at $192.17 on Friday. The company has a debt-to-equity ratio of 1.22, a quick ratio of 1.14 and a current ratio of 1.14. The stock has a market capitalization of $91.71 billion, a P/E ratio of 23.49, a price-to-earnings-growth ratio of 2.75 and a beta of 0.59. Marsh & McLennan Companies, Inc. has a one year low of $156.60 and a one year high of $212.65. The business's fifty day moving average price is $179.88.
Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 21st. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.89 by $0.07. Marsh & McLennan Companies had a net margin of 14.24% and a return on equity of 32.67%. The company had revenue of $7.28 billion for the quarter. The firm's revenue was up 6.2% compared to the same quarter last year. On average, analysts predict that Marsh & McLennan Companies, Inc. will post 10.43 EPS for the current fiscal year.
Marsh & McLennan Companies Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Thursday, July 23rd were given a dividend of $0.99 per share. This represents a $3.96 annualized dividend and a yield of 2.1%. This is a boost from Marsh & McLennan Companies's previous quarterly dividend of $0.90. The ex-dividend date was Thursday, July 23rd. Marsh & McLennan Companies's dividend payout ratio (DPR) is currently 48.41%.
Marsh & McLennan Companies Company Profile
(
Free Report)
Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
